372 related articles for article (PubMed ID: 16670529)
1. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
Wildt S; Munck LK; Vinter-Jensen L; Hanse BF; Nordgaard-Lassen I; Christensen S; Avnstroem S; Rasmussen SN; Rumessen JJ
Inflamm Bowel Dis; 2006 May; 12(5):395-401. PubMed ID: 16670529
[TBL] [Abstract][Full Text] [Related]
2. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis.
Wildt S; Nordgaard I; Hansen U; Brockmann E; Rumessen JJ
J Crohns Colitis; 2011 Apr; 5(2):115-21. PubMed ID: 21453880
[TBL] [Abstract][Full Text] [Related]
3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
4. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
Ringel-Kulka T; Palsson OS; Maier D; Carroll I; Galanko JA; Leyer G; Ringel Y
J Clin Gastroenterol; 2011 Jul; 45(6):518-25. PubMed ID: 21436726
[TBL] [Abstract][Full Text] [Related]
5. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
[TBL] [Abstract][Full Text] [Related]
6. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
[TBL] [Abstract][Full Text] [Related]
7. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of probiotics after colonoscopy.
D'Souza B; Slack T; Wong SW; Lam F; Muhlmann M; Koestenbauer J; Dark J; Newstead G
ANZ J Surg; 2017 Sep; 87(9):E65-E69. PubMed ID: 26183594
[TBL] [Abstract][Full Text] [Related]
9. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
10. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
Klein A; Friedrich U; Vogelsang H; Jahreis G
Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
[TBL] [Abstract][Full Text] [Related]
12.
Martoni CJ; Srivastava S; Leyer GJ
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
[TBL] [Abstract][Full Text] [Related]
13. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
[TBL] [Abstract][Full Text] [Related]
14. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Airaksinen K; Yeung N; Lyra A; Lahtinen SJ; Huttunen T; Shanahan F; Ouwehand AC
Benef Microbes; 2019 Jul; 10(6):617-627. PubMed ID: 31131616
[TBL] [Abstract][Full Text] [Related]
15. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
16. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
Tavasoli S; Jalali S; Naji M; Borumandnia N; Shakiba Majd G; Basiri A; Khosravi Darani K; Karamad D; Tajabadi-Ebrahimi M; Taheri M
Urol J; 2021 Jun; 19(3):179-188. PubMed ID: 34129232
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12
Nocerino R; De Filippis F; Cecere G; Marino A; Micillo M; Di Scala C; de Caro C; Calignano A; Bruno C; Paparo L; Iannicelli AM; Cosenza L; Maddalena Y; Della Gatta G; Coppola S; Carucci L; Ercolini D; Berni Canani R
Aliment Pharmacol Ther; 2020 Jan; 51(1):110-120. PubMed ID: 31797399
[TBL] [Abstract][Full Text] [Related]
18. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
West NP; Horn PL; Pyne DB; Gebski VJ; Lahtinen SJ; Fricker PA; Cripps AW
Clin Nutr; 2014 Aug; 33(4):581-7. PubMed ID: 24268677
[TBL] [Abstract][Full Text] [Related]
19. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]